LAUSR

This study aimed to examine the testicular functions with sperm analysis of patients with COVID‐19. The study was carried out with male patients aged between 18 and 50 years with positive RT‐PCR test and SARS‐CoV‐2 virus between December 2020 and April 2021. A total of 103 participants were included in the study. The mean age was 31.24 ± 5.67 (19–45) years and the mean body mass index of the participants was 28.41 ± 4.68 kg/m2. The patients were divided into two groups, group‐1 was patients who had COVID‐19, group‐2 was healthy men. A semen analysis of both groups was performed, and the serum total testosterone, FSH, LH, anti‐mullerian hormone and Inhibin‐B tests were analysed and recorded. The testicular dimensions and testicular densities were examined by ultrasound and elastography for both groups. Comparing the patient and control groups results, this study found that the sperm count per 1 cc (p = 0.01) and total motility (p = 0.01) in group‐1 was lower than in the control group, the testicular dimensions decreased (for right testis group‐2 was 15.39 ± 4.78 ml versus group‐1 was 12.11 ± 4.62 cm3 p < 0.01, for left testis group‐2 was 16.01 ± 5.12 versus group‐1 was 11.92 ± 4.78 cm3; p < 0.01), and the shear wave velocities were significantly higher in group‐1 patients. In conclusion, sperm parameters deteriorate in men who have symptomatic disease with SARS‐CoV‐2 infection. The fact that the cause of this deterioration is characterized by changes at the cellular level in the testis raises doubts about the persistence of this condition.